Company / Operating Income per Share
Nuvation Bio Inc. Operating Income per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.63
FY2025
5-year range
-$552.48 / -$0.63
FY2021-FY2025
Trend
+76.7%
vs FY2024
Sector context
#81 of 201
Health Care
What the data says
At $-0.63, Nuvation Bio Inc.'s operating income per share ranks #81 of 201 in the Health Care sector. Operating Income per Share has increased for 3 consecutive years, from $-552.48 in FY2022 to $-0.63 in FY2025.
Based on SEC 10-K filings.
-0.63 in FY2025.
Improved from $-456.06 to $-0.63 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#81 of 201 in Health CareTop 40% of 201This company -$0.63 Sector average -$28.56
▼
+97.8% above sector average
Key checks
Key Insights
- Nuvation Bio Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 76.7% year-over-year.
- Ranks #81 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.63 | +76.7% |
| FY2024 | -$2.71 | +99.4% |
| FY2023 | -$456.06 | +17.5% |
| FY2022 | -$552.48 | -17.2% |
| FY2021 | -$471.57 | -105505.9% |
| FY2020 | -$0.45 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026